339 related articles for article (PubMed ID: 33834403)
1. Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression.
Islam F; Gorbovskaya I; Müller DJ
Adv Exp Med Biol; 2021; 1305():231-255. PubMed ID: 33834403
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of antidepressant response: A polygenic approach.
García-González J; Tansey KE; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Žagar T; Czerski PM; Jerman B; Buttenschøn HN; Schulze TG; Zobel A; Farmer A; Aitchison KJ; Craig I; McGuffin P; Giupponi M; Perroud N; Bondolfi G; Evans D; O'Donovan M; Peters TJ; Wendland JR; Lewis G; Kapur S; Perlis R; Arolt V; Domschke K; ; Breen G; Curtis C; Sang-Hyuk L; Kan C; Newhouse S; Patel H; Baune BT; Uher R; Lewis CM; Fabbri C
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():128-134. PubMed ID: 28159590
[TBL] [Abstract][Full Text] [Related]
3. Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts.
Ward J; Graham N; Strawbridge RJ; Ferguson A; Jenkins G; Chen W; Hodgson K; Frye M; Weinshilboum R; Uher R; Lewis CM; Biernacka J; Smith DJ
PLoS One; 2018; 13(9):e0203896. PubMed ID: 30240446
[TBL] [Abstract][Full Text] [Related]
4. Progress and prospects in pharmacogenetics of antidepressant drugs.
Fabbri C; Crisafulli C; Calabrò M; Spina E; Serretti A
Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1157-68. PubMed ID: 27310483
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic studies: a tool to improve antidepressant therapy.
Ramos M; Berrogain C; Concha J; Lomba L; García CB; Ribate MP
Drug Metab Pers Ther; 2016 Dec; 31(4):197-204. PubMed ID: 27889704
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial.
Pérez V; Salavert A; Espadaler J; Tuson M; Saiz-Ruiz J; Sáez-Navarro C; Bobes J; Baca-García E; Vieta E; Olivares JM; Rodriguez-Jimenez R; Villagrán JM; Gascón J; Cañete-Crespillo J; Solé M; Saiz PA; Ibáñez Á; de Diego-Adeliño J; ; Menchón JM
BMC Psychiatry; 2017 Jul; 17(1):250. PubMed ID: 28705252
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic overlap between antidepressant treatment response in major depression & antidepressant associated treatment emergent mania in bipolar disorder.
Nuñez NA; Coombes BJ; Beaupre LM; Ozerdem A; Resendez MG; Romo-Nava F; Bond DJ; Veldic M; Singh B; Moore KM; Betcher HK; Kung S; Prieto ML; Fuentes M; Ercis M; Miola A; Sanchez Ruiz JA; Jenkins G; Batzler A; Leung JG; Cuellar-Barboza A; Tye SJ; McElroy SL; Biernacka JM; Frye MA
Transl Psychiatry; 2024 Feb; 14(1):93. PubMed ID: 38351009
[TBL] [Abstract][Full Text] [Related]
8. A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants.
Kanders SH; Pisanu C; Bandstein M; Jonsson J; Castelao E; Pistis G; Gholam-Rezaee M; Eap CB; Preisig M; Schiöth HB; Mwinyi J
Drug Dev Res; 2020 Feb; 81(1):102-113. PubMed ID: 31617956
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant pharmacogenetics.
Singh AB; Bousman CA; Ng C; Berk M
Curr Opin Psychiatry; 2014 Jan; 27(1):43-51. PubMed ID: 24270480
[TBL] [Abstract][Full Text] [Related]
10. A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression.
McCarthy MJ; Chen Y; Demodena A; Leckband SG; Fischer E; Golshan S; Suppes T; Kelsoe JR
J Psychopharmacol; 2021 Aug; 35(8):992-1002. PubMed ID: 33938307
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association studies in pharmacogenomics of antidepressants.
Lin E; Lane HY
Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525
[TBL] [Abstract][Full Text] [Related]
12. Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics.
Shalimova A; Babasieva V; Chubarev VN; Tarasov VV; Schiöth HB; Mwinyi J
Pharmacogenomics; 2021 Jun; 22(8):485-503. PubMed ID: 34018822
[TBL] [Abstract][Full Text] [Related]
13. Machine learning, pharmacogenomics, and clinical psychiatry: predicting antidepressant response in patients with major depressive disorder.
Bobo WV; Van Ommeren B; Athreya AP
Expert Rev Clin Pharmacol; 2022 Aug; 15(8):927-944. PubMed ID: 35968639
[TBL] [Abstract][Full Text] [Related]
14. Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial).
Minelli A; Barlati S; Vitali E; Bignotti S; Dattilo V; Tura GB; Maffioletti E; Giacopuzzi E; Santoro V; Perusi G; Cobelli C; Magri C; Bonizzato S; Bocchio-Chiavetto L; Spina E; Vita A; Gennarelli M
Trials; 2021 Dec; 22(1):896. PubMed ID: 34895291
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic guidelines and decision support tools for depression treatment: application to late-life.
Chang DD; Eyreeuro HA; Abbott R; Coudreaut M; Baune BT; Shaman JA; Lavretsky H; Lenze EJ; Merrill DA; Singh AB; Mulsant BH; Reynolds CF; Müller DJ; Bousman C
Pharmacogenomics; 2018 Nov; 19(16):1269-1284. PubMed ID: 30422065
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of predicted gene-drug interactions for antidepressants in the treatment of major depressive disorder in the Precision Medicine in Mental Health Care Study.
Ramsey CM; Lynch KG; Thase ME; Gelernter J; Kranzler HR; Pyne JM; Shih MC; Stone A; ; Oslin DW
J Affect Disord; 2021 Mar; 282():1272-1277. PubMed ID: 33601706
[TBL] [Abstract][Full Text] [Related]
17. Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness Studies.
Rosenblat JD; Lee Y; McIntyre RS
J Clin Psychiatry; 2017 Jun; 78(6):720-729. PubMed ID: 28068459
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.
Fabbri C; Di Girolamo G; Serretti A
Am J Med Genet B Neuropsychiatr Genet; 2013 Sep; 162B(6):487-520. PubMed ID: 23852853
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomic Clinical Support Tools for the Treatment of Depression.
Baum ML; Widge AS; Carpenter LL; McDonald WM; Cohen BM; Nemeroff CB;
Am J Psychiatry; 2024 Jul; 181(7):591-607. PubMed ID: 38685859
[TBL] [Abstract][Full Text] [Related]
20. Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.
Kirchheiner J; Bertilsson L; Bruus H; Wolff A; Roots I; Bauer M
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S235-43. PubMed ID: 14677085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
